share_log

HC Wainwright & Co. Downgrades Co-Diagnostics to Neutral, Lowers Price Target to $3

HC Wainwright & Co. Downgrades Co-Diagnostics to Neutral, Lowers Price Target to $3

HC Wainwright & Co.将Co-Diagnostics降级至中性,将目标价下调至3美元
Benzinga ·  2023/03/20 07:51

HC Wainwright & Co. analyst Yi Chen downgrades Co-Diagnostics (NASDAQ:CODX) from Buy to Neutral and lowers the price target from $6 to $3.

HC Wainwright&Co.分析师陈毅将联合诊断公司(纳斯达克代码:CODX)的评级从买入下调至中性,并将目标价从6美元下调至3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发